Invention Grant
US08426404B2 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors
失效
嘧啶取代的苯并咪唑衍生物作为蛋白激酶抑制剂
- Patent Title: Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors
- Patent Title (中): 嘧啶取代的苯并咪唑衍生物作为蛋白激酶抑制剂
-
Application No.: US11915148Application Date: 2006-06-30
-
Publication No.: US08426404B2Publication Date: 2013-04-23
- Inventor: Guobao Zhang , Pingda Ren , Xia Wang , Nathanel Gray , Taebo Sim
- Applicant: Guobao Zhang , Pingda Ren , Xia Wang , Nathanel Gray , Taebo Sim
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Scott W. Reid
- International Application: PCT/US2006/025706 WO 20060630
- International Announcement: WO2007/005673 WO 20070111
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D419/00
Abstract:
The invention provides a novel class of compounds having Formula Ia, wherein each variable is as defined; and pharmaceutical compositions comprising such compounds and methods of using such compounds for inhibiting c-Src, FGFR3, KDR and/or Lck.
Public/Granted literature
- US20080255112A1 Pyrimidine-Substituted Benzimidazole Derivatives as Protein Kinase Inhibitors Public/Granted day:2008-10-16
Information query
